PROCEEDINGS FROM THE INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION WORKING PARTY ON IMMUNOHAEMATOLOGY, WORKSHOP ON THE CLINICAL SIGNIFICANCE OF RED BLOOD CELL ALLOANTIBODIES, SEPTEMBER 9, 2016, DUBAI: Clinical significance of antibodies to antigens in the ABO, MNS, P1PK, Rh, Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Yt, and Xg blood group systems
International Society of Blood Transfusion. Working Party for Red Cell Immunogenetics and Blood Group Terminology. Available from http://www.isbtweb.org/fileadmin/user_upload/Red_Cell_Terminology_and_Immunogenetics/Table_of_blood_group_antigens_within_systems_v8_180620.pdf. Accessed 23 June 2019.International Society of Blood Transfusion. Working Party for Red Cell Immunogenetics and Blood Group Terminology. Available from http://www.isbtweb.org/fileadmin/user_upload/Red_Cell_Terminology_and_Immunogenetics/Table_of_blood_group_antigens_within_systems_v8_180620.pdf. Accessed 23 June 2019.Search in Google Scholar
Daniels G. Human blood groups. 3rd ed. Chichester, UK: Blackwell Science, 2013.DanielsG.Human blood groups. 3rd ed.Chichester, UK: Blackwell Science, 2013.10.1002/9781118493595Search in Google Scholar
Reid ME, Lomas-Francis C, Olsson ML. The blood group antigen factsbook. 3rd ed. Waltham, MA: Academic Press, 2012.ReidMELomas-FrancisCOlssonML.The blood group antigen factsbook. 3rd ed.Waltham, MA: Academic Press, 2012.10.1016/B978-0-12-415849-8.00026-0Search in Google Scholar
Milkins C, Berryman J, Cantwell C, et al. Guidelines for pretransfusion compatibility procedures in blood transfusion laboratories: BCSH guidelines. Transfus Med 2013;23:3–35.MilkinsCBerrymanJCantwellC, Guidelines for pretransfusion compatibility procedures in blood transfusion laboratories: BCSH guidelines. Transfus Med2013;23:3–35.10.1111/j.1365-3148.2012.01199.x23216974Search in Google Scholar
Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007;21:58–71.PooleJDanielsG.Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev2007;21:58–71.10.1016/j.tmrv.2006.08.00317174221Search in Google Scholar
Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology 2009;25:48–59.StorryJROlssonML.The ABO blood group system revisited: a review and update. Immunohematology2009;25:48–59.10.21307/immunohematology-2019-231Search in Google Scholar
Hellberg Å, Westman JS, Thuresson B, Olsson ML. P1PK: the blood group system that changed its name and expanded. Immunohematology 2013;29:23–33.Hellberg Å, WestmanJSThuressonBOlssonML.P1PK: the blood group system that changed its name and expanded. Immunohematology2013;29:23–33.10.21307/immunohematology-2019-120Search in Google Scholar
Duk M, Westerlind U, Norberg T, Pazynina G, Bovin N, Lisowskal E. Specificity of human anti-NOR antibodies, a distinct species of “natural” anti-a-galactosyl antibodies. Glycobiology 2003;13:279–84.DukMWesterlindUNorbergTPazyninaGBovinNLisowskalE.Specificity of human anti-NOR antibodies, a distinct species of “natural” anti-a-galactosyl antibodies. Glycobiology2003;13:279–84.10.1093/glycob/cwg03612626386Search in Google Scholar
Kollamparambil TG, Jani BR, Aldouri M, Soe A, Ducker DA. Anti-CW alloimmunization presenting as hydrops fetalis. Acta Paediatr 2005;94:499–507.KollamparambilTGJaniBRAldouriMSoeADuckerDA.Anti-CW alloimmunization presenting as hydrops fetalis. Acta Paediatr2005;94:499–507.10.1111/j.1651-2227.2005.tb01924.x16092467Search in Google Scholar
Hustinx H, Lejon-Crottet S, Henny C, et al. LUIT: a novel high incidence antigen in the Lutheran blood group system (abstract). Vox Sang 2014;107:172.HustinxHLejon-CrottetSHennyC, LUIT: a novel high incidence antigen in the Lutheran blood group system (abstract). Vox Sang2014;107:172.Search in Google Scholar
Scharberg EA, Wieckhusen C, Luz B, et al. Fatal hemolytic disease of the newborn caused by an antibody to KEAL, a new low-prevalence Kell blood group antigen. Transfusion 2017;57:217–8.ScharbergEAWieckhusenCLuzB, Fatal hemolytic disease of the newborn caused by an antibody to KEAL, a new low-prevalence Kell blood group antigen. Transfusion2017;57:217–8.10.1111/trf.1385227679424Search in Google Scholar
Hoglund P, Rosengren-Lindquist R, Wikman AT. A severe haemolytic transfusion reaction caused by anti-Lea active at 37°C. Blood Transfus 2013;11:456–9.HoglundPRosengren-LindquistRWikmanAT.A severe haemolytic transfusion reaction caused by anti-Lea active at 37°C. Blood Transfus2013;11:456–9.Search in Google Scholar
Irani MS, Figuerona D, Savage G. Acute hemolytic transfusion reaction due to anti-Leb. Transfusion 2015;55:2486–8.IraniMSFigueronaDSavageG.Acute hemolytic transfusion reaction due to anti-Leb. Transfusion2015;55:2486–8.10.1111/trf.1317826018602Search in Google Scholar
Duncan V, Pham HP, Williams LA III. A possible case of haemolytic transfusion reaction caused by anti-Lea antibody. Blood Transfus 2015;13:535–6.DuncanVPhamHPWilliamsLAIII.A possible case of haemolytic transfusion reaction caused by anti-Lea antibody. Blood Transfus2015;13:535–6.Search in Google Scholar
PHB Bolton-Maggs (Ed), D Poles et al. on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2017 Annual SHOT Report (2018). Available from https://www.shotuk.org/wp-content/uploads/myimages/SHOT-Report-2017-WEB-Final-v4-25-9-18.pdf.PHBBolton-Maggs (Ed), DPoleson behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2017 Annual SHOT Report (2018). Available from https://www.shotuk.org/wp-content/uploads/myimages/SHOT-Report-2017-WEB-Final-v4-25-9-18.pdf.Search in Google Scholar
Poole J, Thornton NM, Tilley L. Novel high incidence antigen in the Diego blood group system (DISK) and clinical significance of anti-DISK (abstract). Vox Sang 2010;99(Suppl 1):30.PooleJThorntonNMTilleyL.Novel high incidence antigen in the Diego blood group system (DISK) and clinical significance of anti-DISK (abstract). Vox Sang2010;99(Suppl 1):30.Search in Google Scholar
Laundy R, Karamatic Crew V, Davies H, et al. A novel high incidence antigen in the Yt blood group system (abstract). Transfus Med 2017;27(Suppl 2):42–3.LaundyRKaramatic CrewVDaviesH, A novel high incidence antigen in the Yt blood group system (abstract). Transfus Med2017;27(Suppl 2):42–3.Search in Google Scholar
Karamatic Crew V, Laundy R, McNeill A, et al. Serological and molecular characterisation of two novel high frequency antigens in the Yt blood group system (abstract). Vox Sang 2018;113(Suppl 1):63.Karamatic CrewVLaundyRMcNeillA, Serological and molecular characterisation of two novel high frequency antigens in the Yt blood group system (abstract). Vox Sang2018;113(Suppl 1):63.Search in Google Scholar
Baglow L, Laundy R, Karamatic Crew V, et al. Three new unrelated examples of the rare YTEG–phenotype and anti-YTEG (abstract). Transfus Med 2018;28(Suppl 1):40.BaglowLLaundyRKaramatic CrewV, Three new unrelated examples of the rare YTEG–phenotype and anti-YTEG (abstract). Transfus Med2018;28(Suppl 1):40.Search in Google Scholar
Thornton N, Karamatic Crew V, Muniz E, et al. Four examples of anti-CD99 and discovery of the molecular bases of the rare CD99–phenotype (abstract). Vox Sang 2015;109(Suppl 1):50.ThorntonNKaramatic CrewVMunizE, Four examples of anti-CD99 and discovery of the molecular bases of the rare CD99–phenotype (abstract). Vox Sang2015;109(Suppl 1):50.Search in Google Scholar
